Not so simple: the challenge of developing a non-motor symptoms app (NMS Assist) for people with Parkinson’s (PwP)
Objective: To evaluate usability and identify the challenges for PwP when using NMS Assist. Background: There is great potential for mHealth technologies, such as apps,…Diagnostic value of vagus nerve ultrasound in Parkinson’s disease
Objective: To detect by the ultrasound (US) the possible presence of vagus nerve atrophy in patients with PD and its relation to severity of motor,…Self-perceived stigma and motor symptoms in patients with Parkinson’s disease
Objective: To identify the variables of activities of daily living (ADL) and motor function associated with self-perceived stigma (self-stigma) in patients with Parkinson’s disease (PD).…Prevalence, Impact, and Suboptimal Treatment of Depression in the Fox Insight Cohort
Objective: Addressing unmet mental health needs in Parkinson’s disease (PD) requires delineating their scope and impact. This study evaluated (1) depressive symptom prevalence and treatment…Impulse control disorder and ventral striatum dopamine D3 receptor availability in Parkinson’s disease
Objective: To investigate the relationship between ventral striatum D3 dopamine receptor availability and severity of impulse control disorder (ICD) in Parkinson’s disease (PD). Background: Reduced…Triggers and Alleviating Factors for Fatigue in Parkinson’s Disease
Objective: To examine self-reported triggers of fatigue for individuals with Parkinson’s Disease (PD), the strategies they employ to cope with fatigue, and the types of…Rates of Pharmacological Treatment of Neuropsychiatric Symptoms in Early Parkinson’s Disease
Objective: To determine the rates of pharmacological treatment for neuropsychiatric symptoms (NPS) in patients with early Parkinson’s disease (PD), and identify predictors of under-treatment. Background:…“Familial imprint” of Parkinson disease: the siblings’ cohort of PROPAG-AGEING
Objective: To verify if non-affected siblings (Sibs) of PD patients share candidate PD biomarkers in comparison with de-novo PD patients (PD) and healthy controls (HC).…Data quality, acceptability and reliability of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)
Objective: To analyze the acceptability and reliability of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS). Background: Parkinson’s disease (PD) is a chronic…Quantitative Susceptibility Mapping: an Biomarker for Diagnosis of Parkinson’s Disease and Evaluation Patients’ Condition
Objective: To study deep gray matter susceptibility in Parkinson's Disease (PD) by using quantitative susceptibility mapping (QSM) and to assess the relationship between susceptibility value…
- « Previous Page
- 1
- …
- 29
- 30
- 31
- 32
- 33
- …
- 55
- Next Page »